Trial Profile
Double-blind treatment of outpatients with dysthymic disorder with Wellbutrin XL [bupropion]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary)
- Indications Dysthymic disorder
- Focus Therapeutic Use
- 05 Jun 2007 Status changed from recruiting to completed.
- 06 Nov 2005 New trial record.